2,3-diphosphoglycerate has been researched along with Kidney Failure, Chronic in 23 studies
2,3-Diphosphoglycerate: A highly anionic organic phosphate which is present in human red blood cells at about the same molar ratio as hemoglobin. It binds to deoxyhemoglobin but not the oxygenated form, therefore diminishing the oxygen affinity of hemoglobin. This is essential in enabling hemoglobin to unload oxygen in tissue capillaries. It is also an intermediate in the conversion of 3-phosphoglycerate to 2-phosphoglycerate by phosphoglycerate mutase (EC 5.4.2.1). (From Stryer Biochemistry, 4th ed, p160; Enzyme Nomenclature, 1992, p508)
2,3-bisphosphoglyceric acid : A bisphosphoglyceric acid that is glyceric acid carrying two phospho substituents at positions 2 and 3.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperphosphatemia is a well-recognized complication of chronic kidney disease, and phosphorus kinetics during hemodialysis (HD) remains a vague area of investigation." | 3.77 | Inorganic phosphorus homeostasis during the first hour of dialysis. ( Challa, AS; Dounousi, EC; Karasavvidou, DP; Katopodis, KP; Vlachou, IA, 2011) |
| "Hyperphosphatemia is a well-recognized complication of chronic kidney disease, and phosphorus kinetics during hemodialysis (HD) remains a vague area of investigation." | 1.37 | Inorganic phosphorus homeostasis during the first hour of dialysis. ( Challa, AS; Dounousi, EC; Karasavvidou, DP; Katopodis, KP; Vlachou, IA, 2011) |
| "03) sampled just before dialysis correlated significantly and positively with the total weekly dosage of erythropoietin given to the patients." | 1.30 | Oxygen and 2,3 biphosphoglycerate (2,3-BPG) during haemodialysis. ( Andersen, EM; Jensen, HA; Jørgensen, LG; Nielsen, AL, 1998) |
| "Eleven patients with chronic renal failure who were being treated with haemodialysis three times a week were monitored for a total of 34 haemodialysis sessions." | 1.30 | Oxygen and 2,3 biphosphoglycerate (2,3-BPG) during haemodialysis. ( Andersen, EM; Jensen, HA; Jørgensen, LG; Nielsen, AL, 1998) |
| "It is well established that ESRD patients can tolerate a greater degree of anaemia than anaemic subjects of other aetiologies." | 1.28 | Adaptation of uraemic patients to anaemia: A31 P nuclear magnetic resonance study. ( Baz, M; Berland, Y; Crevat, A; Elsen, R; Klinkmann, H; Monti, JP, 1990) |
| "In a group of 69 patients with chronic renal failure, 18 patients after renal transplantation and 8 healthy controls the influence of inorganic phosphate and pH of plasma and of the hemoglobin concentration in whole blood on the 2,3-DPG concentration in red blood cells was investigated." | 1.26 | 2,3-Biphosphoglycerate, inorganic phosphate, pH and hemoglobin concentration in chronic renal failure of man. ( Elsner, R; Gerber, G; Holzhütter, H; Rapoport, I; Röseler, E, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (56.52) | 18.7374 |
| 1990's | 6 (26.09) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, Z | 1 |
| Luo, R | 1 |
| Xie, T | 1 |
| Zhang, W | 1 |
| Liu, H | 1 |
| Wang, W | 1 |
| Tao, L | 1 |
| Kellems, RE | 1 |
| Xia, Y | 1 |
| Katopodis, KP | 1 |
| Dounousi, EC | 1 |
| Challa, AS | 1 |
| Vlachou, IA | 1 |
| Karasavvidou, DP | 1 |
| Monti, JP | 2 |
| Baz, M | 1 |
| Klinkmann, H | 1 |
| Elsen, R | 1 |
| Berland, Y | 1 |
| Crevat, A | 1 |
| Bober, J | 1 |
| Kedzierska, K | 1 |
| Safranow, K | 1 |
| Kwiatkowska, E | 1 |
| Jakubowska, K | 1 |
| Herdzik, E | 1 |
| Dołegowska, B | 1 |
| Domański, L | 1 |
| Ciechanowski, K | 1 |
| Kang, SK | 1 |
| Park, SK | 1 |
| Oimomi, M | 1 |
| Ishikawa, K | 1 |
| Kawasaki, T | 1 |
| Kubota, S | 1 |
| Takagi, K | 1 |
| Tanke, G | 1 |
| Yoshimura, Y | 1 |
| Takase, S | 1 |
| Sato, E | 1 |
| Baba, S | 1 |
| Agrafiotis, A | 1 |
| Camus, F | 1 |
| Rottembourg, J | 1 |
| Eugene, L | 1 |
| Legrain, M | 1 |
| Gerber, G | 1 |
| Holzhütter, H | 2 |
| Röseler, E | 1 |
| Rapoport, I | 2 |
| Elsner, R | 1 |
| Summerfield, GP | 1 |
| Bellingham, AJ | 1 |
| Manlove, L | 1 |
| Forbes, AM | 1 |
| Goldsmith, HJ | 1 |
| Rubio Pérez, P | 1 |
| Alvarez-Sala Walther, JL | 1 |
| Gallardo López, J | 1 |
| Naranjo Gómez, P | 1 |
| de Pablos Mateos, I | 1 |
| Rentero Rodríguez, RM | 1 |
| Sánchez Sánchez, ML | 1 |
| Espinós Pérez, D | 1 |
| Heierli, C | 1 |
| Thölen, H | 1 |
| Brunet, PJ | 1 |
| Berland, YF | 1 |
| Vanuxem, DC | 1 |
| Vanuxem, PA | 1 |
| Crevat, AD | 1 |
| Rodriguez-Franco, F | 1 |
| Tesouro-Diez, MA | 1 |
| Rodriguez-Sanchez, M | 1 |
| Wehler, M | 1 |
| Grote, J | 1 |
| Klehr, HU | 1 |
| Nielsen, AL | 1 |
| Andersen, EM | 1 |
| Jørgensen, LG | 1 |
| Jensen, HA | 1 |
| Umimoto, K | 1 |
| Hirai, Y | 1 |
| Hayashi, T | 1 |
| Tanaka, H | 1 |
| Engelhardt, I | 1 |
| Drung, I | 1 |
| Schmidt, G | 1 |
| Jabłońska-Skwiecinśka, E | 2 |
| Staniszewska, K | 2 |
| Kowalska, H | 2 |
| Caimi, G | 1 |
| Vaccaro, F | 1 |
| Romano, A | 1 |
| Serra, A | 1 |
| Picone, FP | 1 |
| D'Asaro, S | 1 |
| Catania, A | 1 |
| Sarno, A | 1 |
| Ando, R | 1 |
| Saito, H | 1 |
| Takeuchi, J | 1 |
| Solomon, LR | 1 |
| Hendler, ED | 1 |
| Martins e Silva, J | 1 |
1 review available for 2,3-diphosphoglycerate and Kidney Failure, Chronic
| Article | Year |
|---|---|
[Erythrocyte mechanisms of adaptation to hypoxia in chronic renal insufficiency].
Topics: 2,3-Diphosphoglycerate; Adaptation, Physiological; Adenosine Triphosphate; Anemia; Animals; Diphosph | 1985 |
22 other studies available for 2,3-diphosphoglycerate and Kidney Failure, Chronic
| Article | Year |
|---|---|
Erythrocyte Adenosine A2B Receptor-Mediated AMPK Activation: A Missing Component Counteracting CKD by Promoting Oxygen Delivery.
Topics: 2,3-Diphosphoglycerate; Adult; AMP-Activated Protein Kinases; Angiotensin II; Animals; Disease Progr | 2019 |
Inorganic phosphorus homeostasis during the first hour of dialysis.
Topics: 2,3-Diphosphoglycerate; Adult; Aged; Aged, 80 and over; Biomarkers; Erythrocytes; Female; Follow-Up | 2011 |
Adaptation of uraemic patients to anaemia: A31 P nuclear magnetic resonance study.
Topics: 2,3-Diphosphoglycerate; Adaptation, Physiological; Anemia; Case-Control Studies; Erythrocytes; Hemog | 1990 |
Influence of glucose in dialyzing fluid on purine concentrations in hemodialyzed patients with chronic renal failure.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Adult; Aged; Dialysis Solutions; Erythrocytes; Femal | 2003 |
2,3-diphosphoglyceric acid changes in uremia and during hemodialysis.
Topics: 2,3-Diphosphoglycerate; Adult; Blood Glucose; Female; Humans; Hydrogen-Ion Concentration; Kidney Fai | 1986 |
[Studies on hemorheology as causative factors of tissue hypoxia in renal failure].
Topics: 2,3-Diphosphoglycerate; Blood Viscosity; Diphosphoglyceric Acids; Glycated Hemoglobin; Humans; Hypox | 1983 |
Erythrocyte organic phosphates and whole blood oxygen affinity in patients on continuous ambulatory peritoneal dialysis.
Topics: 2,3-Diphosphoglycerate; Acidosis; Adult; Aged; Blood Urea Nitrogen; Creatinine; Diphosphoglyceric Ac | 1982 |
2,3-Biphosphoglycerate, inorganic phosphate, pH and hemoglobin concentration in chronic renal failure of man.
Topics: 2,3-Diphosphoglycerate; Diphosphoglyceric Acids; Hemoglobins; Humans; Hydrogen-Ion Concentration; Ki | 1981 |
Erythrocyte metabolism in patients on haemodialysis and continuous ambulatory peritoneal dialysis.
Topics: 2,3-Diphosphoglycerate; Blood Glucose; Diphosphoglyceric Acids; Erythrocytes; Glycolysis; Hemoglobin | 1982 |
[Changes in erythrocyte levels of 2,3-diphosphoglyceric acid in patients with severe chronic renal insufficiency].
Topics: 2,3-Diphosphoglycerate; Adult; Aged; Anemia; Diphosphoglyceric Acids; Erythrocytes; Female; Humans; | 1981 |
Metabolites of glucose in the blood of patients with renal failure.
Topics: 2,3-Diphosphoglycerate; Acetaldehyde; Acetates; Acetoin; Adult; Aged; Blood Glucose; Butylene Glycol | 1981 |
Opposite effects of urea on hemoglobin-oxygen affinity in anemia of chronic renal failure.
Topics: 2,3-Diphosphoglycerate; Anemia; Diphosphoglyceric Acids; Hemoglobins; Humans; Kidney Failure, Chroni | 1995 |
Concentrations of 2,3-diphosphoglycerate (2,3-DPG) in canine blood (healthy dogs, dogs with cardiopulmonary insufficiency and dogs with renal insufficiency).
Topics: 2,3-Diphosphoglycerate; Animals; Diphosphoglyceric Acids; Dog Diseases; Dogs; Female; Heart Diseases | 1994 |
Hemoglobin oxygen affinity and acid-base status in blood of chronic hemodialysis patients.
Topics: 2,3-Diphosphoglycerate; Acetates; Acid-Base Equilibrium; Adult; Aged; Bicarbonates; Carbon Dioxide; | 1994 |
Oxygen and 2,3 biphosphoglycerate (2,3-BPG) during haemodialysis.
Topics: 2,3-Diphosphoglycerate; Aged; Erythropoietin; Female; Hemoglobins; Humans; Kidney Failure, Chronic; | 1998 |
The effect of biofiltration on red blood cells 2.3-diphosphoglycerate and pH.
Topics: 2,3-Diphosphoglycerate; Bicarbonates; Cross-Over Studies; Diabetic Nephropathies; Erythrocytes; Hemo | 2000 |
Influence of erythropoietin treatment on 2,3-bisphosphoglycerate and O2-affinity of red blood cells in children with renal anemia.
Topics: 2,3-Diphosphoglycerate; Adolescent; Anemia; Diphosphoglyceric Acids; Erythrocytes; Erythropoietin; F | 1990 |
The red cell sodium, potassium, inorganic phosphate, ATP and 2,3DPG concentrations in chronic renal failure.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Diphosphoglyceric Acids; Erythrocytes; Humans; Kidne | 1987 |
[Chronic renal insufficiency undergoing conservative therapy: hemorheological pattern and erythrocytic metabolic parameters].
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Adult; Aged; Diphosphoglyceric Acids; Erythrocyte Ag | 1989 |
[Sodium, potassium, ATP, 2,3-diphosphoglycerate and inorganic phosphate levels in erythrocytes of patients on hemodialysis].
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Adult; Diphosphoglyceric Acids; Erythrocytes; Female | 1988 |
Factors that affect oxygen affinity of hemoglobin in chronic hemodialysis patients.
Topics: 2,3-Diphosphoglycerate; Adult; Carbon Dioxide; Diabetic Nephropathies; Diphosphoglyceric Acids; Eryt | 1987 |
Androgen therapy in haemodialysis patients. II. Effects on red cell metabolism.
Topics: 2,3-Diphosphoglycerate; Androgens; Diphosphoglyceric Acids; Erythrocyte Count; Erythrocytes; Humans; | 1987 |